^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

IGFBP3 (Insulin-like growth factor binding protein 3)

i
Other names: IGFBP3, BP-53, IBP3, Insulin-like growth factor binding protein 3
17d
Transgelin: a tumor suppressor candidate in neuroblastoma. (PubMed, Carcinogenesis)
In TH-MYCN mice, which have a high frequency of NB development, Tagln overexpression by induction of the murine Tagln gene significantly reduced tumor formation and prolonged survival. In conclusion, these in vitro and in vivo analyses suggest that TAGLN is a candidate tumor suppressor gene in NB.
Journal
|
PDGFRA (Platelet Derived Growth Factor Receptor Alpha) • MYCN (MYCN Proto-Oncogene BHLH Transcription Factor) • KLF4 (Kruppel-like factor 4) • SOX2 • POU5F1 (POU Class 5 Homeobox 1) • APOE (Apolipoprotein E) • IGFBP3 (Insulin-like growth factor binding protein 3) • IGFBP7 (Insulin Like Growth Factor Binding Protein 7) • TAGLN (Transgelin)
17d
Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study. (PubMed, Br J Haematol)
Corroborating previous findings, in a secondary analysis, IGF-I levels were associated with the risk of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in males with higher body mass index (HR1-SD in obese male = 1.36, 95% CI: 1.14-1.61). Our serological and MR analyses suggest a contributing role of IGF-I in the susceptibility of MM; the CLL/SLL findings warrant further investigation considering sex-specific adiposity.
Journal
|
IGF1 (Insulin-like growth factor 1) • IGFBP3 (Insulin-like growth factor binding protein 3)
17d
Insulin-like growth factor binding protein-3 serves as a biomarker for resistance to enzalutamide in prostate cancer. (PubMed, Apoptosis)
This model can accurately predict the clinical prognosis of prostate cancer patients after surgery. Moreover, IGFBP3 can be used as a potential therapeutic target for ENZ resistance in prostate cancer.
Journal
|
IGFBP3 (Insulin-like growth factor binding protein 3)
|
Xtandi (enzalutamide)
1m
Genetic evidence for potential molecular mediators underlying the causal relationship between obesity and breast cancer: a two-step, two-sample Mendelian randomization study. (PubMed, BMC Cancer)
Chronic low-grade inflammation is a vital pathway linking genetically predicted BMI to breast cancer risk. Genetically predicted BMI is associated with higher genetically predicted CRP levels, potentially through a pathway involving reduced IGF-1 levels, which may attenuate the inverse association between genetically predicted BMI and breast cancer risk.
Journal • Causal relationship
|
IGF1 (Insulin-like growth factor 1) • IGFBP3 (Insulin-like growth factor binding protein 3) • CRP (C-reactive protein) • LEP (Leptin)
1m
Associations of breast DNA methylation-based measures of biological ageing with obesity-related breast cancer risk markers. (PubMed, Epigenetics)
Epigenetic age in breast tissue, particularly Grim and DNAmTL, is associated with obesity-related metabolic markers, independent of chronological age, BMI, and smoking. Although limited by a moderate sample size, our findings indicate a potential biological pathway linking mAge-related metabolic dysregulation that may provide insight into breast cancer risk.
Journal
|
IGF1 (Insulin-like growth factor 1) • IGFBP3 (Insulin-like growth factor binding protein 3) • LEP (Leptin)
1m
Enrollment change
|
ER (Estrogen receptor) • ATM (ATM serine/threonine kinase) • CHEK2 (Checkpoint kinase 2) • IGFBP3 (Insulin-like growth factor binding protein 3)
|
tamoxifen • exemestane
2ms
CASC15 Promotes Cholangiocyte Proliferation and Liver Fibrosis by Regulating the HNRNPU-IGFBP3 Axis in Biliary Atresia. (PubMed, Dig Dis Sci)
This research revealed the crucial role of CASC15/HNRNPU-IGFBP3 regulatory network in the pathogenesis of LF in BA.
Journal
|
IGFBP3 (Insulin-like growth factor binding protein 3)
2ms
Prognostic biomarkers for overall survival in patients undergoing surgery for bone metastases: a pan-cancer study. (PubMed, Front Med (Lausanne))
Tumor-specific and host-related biomarkers (IGFBP-3, NLR, and RDW) improved prognostic stratification beyond tumor type. The proposed nomogram demonstrated good discriminatory performance, supporting its potential use in personalized prognostic assessment and treatment planning.
Journal • Pan tumor
|
IGFBP3 (Insulin-like growth factor binding protein 3)
2ms
Craniofacial and Radiological Features as Diagnostic Clues to Unmask Acromegaly: A Case Report. (PubMed, Cureus)
While acromegaly typically manifests with musculoskeletal changes and endocrine abnormalities - including diabetes mellitus, hypertension, and galactorrhea - it also carries a substantial risk of secondary respiratory and cardiac complications. This report highlights the importance of early diagnosis of acromegaly, specifically in identifying, being cognizant of, and preventing respiratory and cardiac complications.
Journal
|
IGF1 (Insulin-like growth factor 1) • IGFBP3 (Insulin-like growth factor binding protein 3)
3ms
Diabetic Corneal Neuropathy Precedes and Is Associated With Diabetic Retinopathy. (PubMed, Diabetes)
Tear MMP-9, substance P, and IGFBP-3 were significantly altered in DR. Corneal nerve status could be an early indicator and predictor of DR.
Journal
|
MMP9 (Matrix metallopeptidase 9) • IGFBP3 (Insulin-like growth factor binding protein 3)
3ms
The mechanism of Qingyi decoction in improving intestinal barrier injury in pancreatitis: Network pharmacology analysis, machine-learning models, and molecular docking. (PubMed, Medicine (Baltimore))
The results of this study indicated that QYD ameliorates IBI through multiple targets and signaling pathways, with the p53 signaling pathway playing a key role in its therapeutic effect.
Journal
|
IL6 (Interleukin 6) • HIF1A (Hypoxia inducible factor 1, alpha subunit) • PTGS2 (Prostaglandin-Endoperoxide Synthase 2) • IL17A (Interleukin 17A) • IGFBP3 (Insulin-like growth factor binding protein 3) • PACERR (PTGS2 Antisense NFKB1 Complex-Mediated Expression Regulator RNA)
3ms
Cancer-associated fibroblast-derived extracellular vesicles deliver ATP6V1C1 to promote lung adenocarcinoma metastasis via the ID1-IGFBP3 axis. (PubMed, Cell Rep)
This dual action establishes a feedforward loop that exacerbates metastatic progression. Our findings identify ATP6V1C1 as a dual regulator of LUAD metastasis and suggest a potential stroma-targeted therapeutic approach.
Journal
|
IGF1 (Insulin-like growth factor 1) • IGFBP3 (Insulin-like growth factor binding protein 3)